VCAM1 and colitis: Alleviating intestinal inflammation in the DSS-induced colitis mouse model; Attenuating leukocyte infiltration in the colon; Reducing mesenteric lymph node enlargement; Decreasing the expression of VCAM-1, E-selectin, and TNF-α in colon blood vessels.